These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 1343745

  • 1. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
    Avila JL.
    Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
    [Abstract] [Full Text] [Related]

  • 2. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M, de Titto E.
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
    Almeida IC, Ferguson MA, Schenkman S, Travassos LR.
    Biochem J; 1994 Dec 15; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
    [Abstract] [Full Text] [Related]

  • 5. The chronic presence of the parasite, and anti-P autoimmunity in Chagas disease: the Trypanosoma cruzi ribosomal P proteins, and their recognition by the host immune system.
    Kaplan D, Vazquez M, Lafon S, Schijman AG, Levitus G, Levin MJ.
    Biol Res; 1993 Dec 15; 26(1-2):273-7. PubMed ID: 7545503
    [Abstract] [Full Text] [Related]

  • 6. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH, López NC, Ramírez GA, Valck CE, Molina MC, Aguilar L, Rodríguez M, Maldonado I, Martínez R, González C, Troncoso R, Lavandero S, Gingras AR, Schwaeble W, Ferreira A.
    Mol Immunol; 2009 Mar 15; 46(6):1092-9. PubMed ID: 19108895
    [Abstract] [Full Text] [Related]

  • 7. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
    Bonfa E, Viana VS, Barreto AC, Yoshinari NH, Cossermelli W.
    J Immunol; 1993 May 01; 150(9):3917-23. PubMed ID: 8473740
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Partial purification and use of Trypanosoma cruzi glycosidic fractions for Chagas disease diagnosis].
    De Lima Rivero AR, Farías Tamoy MN, Tortolero Leal E, Navarro Aguilera MC, Contreras Alvarez VT.
    Acta Cient Venez; 2001 May 01; 52(4):235-47. PubMed ID: 11915441
    [Abstract] [Full Text] [Related]

  • 11. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES, Shikanai-Yasuda MA, Stolf AM.
    J Clin Lab Anal; 1996 May 01; 10(6):407-13. PubMed ID: 8951611
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C, De Diego JL, Bonay P, Gironés N, Fresno M.
    Biol Res; 1993 May 01; 26(1-2):209-18. PubMed ID: 7670533
    [Abstract] [Full Text] [Related]

  • 14. Human humoral immunity to hsp70 during Trypanosoma cruzi infection.
    Engman DM, Dragon EA, Donelson JE.
    J Immunol; 1990 May 15; 144(10):3987-91. PubMed ID: 2110215
    [Abstract] [Full Text] [Related]

  • 15. Evidence for cross-reactivity between antigen derived from Trypanosoma cruzi and myelin basic protein in experimental Chagas disease.
    Al-Sabbagh A, Garcia CA, Diaz-Bardales BM, Zaccarias C, Sakurada JK, Santos LM.
    Exp Parasitol; 1998 Jul 15; 89(3):304-11. PubMed ID: 9676708
    [Abstract] [Full Text] [Related]

  • 16. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence.
    Zingales B, Golgher DB, Marmorato PG, Souto RP, Gruber A.
    Biol Res; 1993 Jul 15; 26(1-2):89-100. PubMed ID: 7670551
    [Abstract] [Full Text] [Related]

  • 17. Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein.
    Díez H, Guzmán F, Alba MP, Cuéllar A, Thomas MC, López MC, Rosas F, Velasco V, González JM, Patarroyo ME, Puerta CJ.
    Peptides; 2007 Aug 15; 28(8):1520-6. PubMed ID: 17683828
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Trypanosoma cruzi tubulin eliminated in the urine of the infected host.
    Bertot GM, Corral RS, Fresno M, Rodríguez C, Katzin AM, Grinstein S.
    J Parasitol; 1998 Jun 15; 84(3):608-14. PubMed ID: 9645865
    [Abstract] [Full Text] [Related]

  • 20. Antibodies to T. cruzi cytosol acidic antigens (FIV) in Chagas' disease recognize parasite cell surface and human heart epitopes.
    Gea S, Gruppi A, Basso B, Menso E, Vottero-Cima E.
    J Clin Lab Immunol; 1990 Apr 15; 31(4):183-7. PubMed ID: 1726727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.